Literature DB >> 33158931

Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke.

Tiantian Zhu1, Jinrui Cui1, Mark O Goodarzi2.   

Abstract

Polycystic ovary syndrome (PCOS) has been associated with diabetes and cardiovascular disease; however, whether the relationship is causal is uncertain. We conducted a two-sample Mendelian randomization study to investigate the associations of PCOS with type 2 diabetes, coronary heart disease (CHD), and stroke. Association between PCOS and diabetes risk was examined in European and Asian cohorts, both sex specific and sex combined. Causal effects of PCOS on risks of CHD and stroke were evaluated in European cohorts. Stroke was analyzed as any stroke as well as four subtypes of stroke (ischemic, large artery, cardioembolic, small vessel). We found no association of genetically predicted PCOS with risk of diabetes, CHD, or stroke. This suggests that PCOS in and of itself does not increase the risk of these outcomes. Other features of PCOS (obesity, elevated testosterone, low sex hormone binding globulin) may explain the association between PCOS and cardiometabolic diseases. In light of these results, efforts to prevent cardiometabolic complications in PCOS should focus on women with high-risk features rather than all women with PCOS.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2020        PMID: 33158931     DOI: 10.2337/db20-0800

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

Review 1.  Altered Molecular Pathways and Biomarkers of Endometrial Receptivity in Infertile Women with Polycystic Ovary Syndrome.

Authors:  Fei Guo; Yufan Huang; Taniya Fernando; Yingli Shi
Journal:  Reprod Sci       Date:  2022-01-10       Impact factor: 3.060

2.  A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification.

Authors:  Olatokunbo Osibogun; Oluseye Ogunmoroti; Olamide B Kolade; Allison G Hays; Victor Okunrintemi; Anum S Minhas; Martha Gulati; Erin D Michos
Journal:  J Womens Health (Larchmt)       Date:  2022-05-16       Impact factor: 3.017

3.  The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population.

Authors:  Fei Guo; Zhentao Gong; Taniya Fernando; Lingshan Zhang; Xiaoyong Zhu; Yingli Shi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-04       Impact factor: 6.055

Review 4.  Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.

Authors:  Tiantian Zhu; Mark O Goodarzi
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 6.134

5.  Follicular fluid-derived exosomal miR-143-3p/miR-155-5p regulate follicular dysplasia by modulating glycolysis in granulosa cells in polycystic ovary syndrome.

Authors:  Jianping Cao; Peng Huo; Kuiqing Cui; Huimei Wei; Junna Cao; Jinyuan Wang; Qingyou Liu; Xiaocan Lei; Shun Zhang
Journal:  Cell Commun Signal       Date:  2022-05-09       Impact factor: 7.525

6.  Causal relationship between polycystic ovary syndrome and coronary artery disease: A Mendelian randomisation study.

Authors:  Pomme I H G Simons; Merel E B Cornelissen; Olivier Valkenburg; N Charlotte Onland-Moret; Yvonne T van der Schouw; Coen D A Stehouwer; Stephen Burgess; Martijn C G J Brouwers
Journal:  Clin Endocrinol (Oxf)       Date:  2021-09-15       Impact factor: 3.523

Review 7.  Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review.

Authors:  Sarantis Livadas; Panagiotis Anagnostis; Julia K Bosdou; Dimitra Bantouna; Rodis Paparodis
Journal:  World J Diabetes       Date:  2022-01-15

8.  Profile of Bile Acid Metabolomics in the Follicular Fluid of PCOS Patients.

Authors:  Xiao Yang; Richao Wu; Dan Qi; Linlin Fu; Tian Song; Ying Wang; Yuehong Bian; Yuhua Shi
Journal:  Metabolites       Date:  2021-12-06

Review 9.  Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS).

Authors:  Svetlana Spremović Rađenović; Miljan Pupovac; Mladen Andjić; Jovan Bila; Svetlana Srećković; Aleksandra Gudović; Biljana Dragaš; Nebojša Radunović
Journal:  Biomedicines       Date:  2022-01-07

10.  Association of Prx4, Total Oxidant Status, and Inflammatory Factors with Insulin Resistance in Polycystic Ovary Syndrome.

Authors:  Sahar Mazloomi; Nasrin Sheikh; Marzieh Sanoee Farimani; Shamim Pilehvari
Journal:  Int J Endocrinol       Date:  2021-06-22       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.